Works by Yang, Wenying

Results: 142

Multi-omics exploration of CAV1<sup>+</sup> tumor epithelial subcelltype in oral squamous cell carcinoma and its impact on the immune microenvironment.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02843-2

By:

Shi, Yan'an;
Shao, Yiting;
Xia, Bin;
Yang, Wenying;
Wang, Yan;
Yu, Lifu;
Zhang, Yonghui

Publication type:

Article

Worse Pancreatic [beta]-cell Function and Better Insulin Sensitivity in Older Chinese Without Diabetes.

Published in:

2014

By:

Xiao, Jianzhong;
Weng, Jianping;
Ji, Linong;
Jia, Weiping;
Lu, Juming;
Shan, Zhongyan;
Liu, Jie;
Tian, Haoming;
Ji, Qiuhe;
Yang, Zhaojun;
Yang, Wenying;
China National Diabetes and Metabolic Disorders Study Group

Publication type:

Journal Article

Worse Pancreatic β-cell Function and Better Insulin Sensitivity in Older Chinese Without Diabetes.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2014, v. 69, n. 4, p. 463, doi. 10.1093/gerona/glt104

By:

Xiao, Jianzhong;
Weng, Jianping;
Ji, Linong;
Jia, Weiping;
Lu, Juming;
Shan, Zhongyan;
Liu, Jie;
Tian, Haoming;
Ji, Qiuhe;
Yang, Zhaojun;
Yang, Wenying

Publication type:

Article

iGlarLixi provides improved early glycaemic control after 12 weeks of treatment compared with basal insulin in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN studies.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 5, p. 2593, doi. 10.1111/dom.16260

By:

Song, Lulu;
Yuan, Xiaoyong;
Huang, Shan;
Zhang, Yawei;
Lauand, Felipe;
Wang, Zhini;
Zhang, Jie;
Du, Qin;
Kang, Lei;
Yang, Wenying;
Guo, Xiaohui

Publication type:

Article

Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 953, doi. 10.1111/dom.16095

By:

Wang, Weihao;
Han, Yujia;
Jiang, Xun;
Shao, Jian;
Zhang, Jia;
Zhou, Kaixin;
Yang, Wenying;
Pan, Qi;
Nie, Zedong;
Guo, Lixin

Publication type:

Article

Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2774, doi. 10.1111/dom.15596

By:

Wang, Yao;
Jiang, Chengxia;
Dong, Xiaolin;
Chen, Mingwei;
Gu, Qin;
Zhang, Lihui;
Fu, Yanqin;
Pan, Tianrong;
Bi, Yan;
Song, Weihong;
Xu, Jing;
Lu, WeiPing;
Sun, Xiaodong;
Ye, Zi;
Zhang, Danli;
Peng, Liang;
Lin, Xiang;
Dai, Wei;
Wang, Quanren;
Yang, Wenying

Publication type:

Article

Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1197, doi. 10.1111/dom.15414

By:

Yang, Wenying;
Guo, Xiaohui;
Lauand, Felipe;
Li, Lingyu;
Fang, Hexin;
Du, Qin;
Kang, Lei

Publication type:

Article

Front Cover.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. C1, doi. 10.1111/dom.15460

By:

Feng, Lingge;
Chen, Chunxiang;
Guo, Quanle;
Chen, Li;
Yang, Wenying

Publication type:

Article

Improvement of early‐phase insulin secretion is an independent factor for achieving glycaemic control: A pooled analysis of SEED and DAWN study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 745, doi. 10.1111/dom.15370

By:

Feng, Lingge;
Chen, Chunxiang;
Guo, Quanle;
Chen, Li;
Yang, Wenying

Publication type:

Article

iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2005, doi. 10.1111/dom.15074

By:

Guo, Xiaohui;
Yang, Wenying;
Zhang, Junqing;
Dong, Xiaolin;
Liu, Ming;
Gu, Shenghong;
Lauand, Felipe;
Li, Lingyu;
Huang, Qiong;
Kang, Lei;
Souhami, Elisabeth

Publication type:

Article

Saxagliptin combined with additional oral antihyperglycaemic agents in drug‐naive diabetic patients with high glycosylated haemoglobin: A 24‐week, multicentre, randomized, open‐label, active parallel‐controlled group clinical trial in China (SUCCESS)

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 272, doi. 10.1111/dom.14873

By:

Chen, Xiaoping;
Jiang, Hongwei;
Li, Hongmei;
Kuang, Hongyu;
Chen, Li;
Ma, Jianhua;
Zhang, Qiu;
Pan, Tianrong;
Yang, Wenying

Publication type:

Article

Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: The LixiLan‐O‐AP randomized controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1522, doi. 10.1111/dom.14722

By:

Yang, Wenying;
Dong, Xiaolin;
Li, Qingju;
Cheng, Zhifeng;
Yuan, Guoyue;
Liu, Ming;
Xiao, Jianzhong;
Gu, Shenghong;
Niemoeller, Elisabeth;
Chen, Lijuan;
Ping, Lin;
Souhami, Elisabeth

Publication type:

Article

Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 642, doi. 10.1111/dom.14231

By:

Yang, Wenying;
Xu, Xiangjin;
Lei, Tao;
Ma, Jianhua;
Li, Ling;
Shen, Jie;
Ye, Binqi;
Zhu, Sandy;
Meinicke, Thomas

Publication type:

Article

Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: A multicentre, randomized, double‐blind, placebo‐controlled phase 3a clinical trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 116, doi. 10.1111/dom.14198

By:

Shuai, Ying;
Yang, Gangyi;
Zhang, Qiu;
Li, Wei;
Luo, Yong;
Ma, Jianhua;
Chen, Daoxiong;
Yang, Jialin;
Wang, Xinjun;
Hu, Ji;
Xu, Ning;
Yang, Wenying

Publication type:

Article

Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open‐label, randomized‐controlled FPG GOAL trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1973, doi. 10.1111/dom.13733

By:

Yang, Wenying;
Ma, Jianhua;
Yuan, Guoyue;
Li, Ling;
Zhang, Min;
Lu, Yibing;
Ye, Xinhua;
Song, Weihong;
Liu, Ming;
Wu, Jun;
Chen, Riqiu;
Li, Yunguang;
Zhang, Xia;
Cui, Nan;
Yang, Jinkui

Publication type:

Article

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open‐label, 2:1 randomized, treat‐to‐target trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1652, doi. 10.1111/dom.13703

By:

Yang, Wenying;
Nielsen, Anne M.;
Pan, Lili;
Liu, Weihong;
Zhao, Weigang;
Ma, Jianhua;
Hong, Tianpei;
Liu, Ming;
Miao, Heng;
Peng, Yongde;
Wang, Changjiang;
Xu, Xiangjin;
Yang, Tao

Publication type:

Article

Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 335, doi. 10.1111/dom.13072

By:

Yang, Wenying;
Min, Kyungwan;
Zhou, Zhiguang;
Li, Ling;
Xu, XiangJin;
Zhu, Dalong;
Venkateshwar Rao, A.;
Murthy, Laxminarayanappa Sreenivasa;
Zhang, Nianxian;
Li, Ivy;
Niemoeller, Elisabeth;
Shang, Shuhua

Publication type:

Article

Comparative effectiveness and safety of different basal insulins in a real-world setting.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 8, p. 1116, doi. 10.1111/dom.12920

By:

Ji, Linong;
Zhang, Puhong;
Zhu, Dongshan;
Lu, Juming;
Guo, Xiaohui;
Wu, Yangfeng;
Li, Xian;
Ji, Jiachao;
Jia, Weiping;
Yang, Wenying;
Zou, Dajin;
Zhou, Zhiguang;
Gao, Yan;
Garg, Satish K.;
Pan, Changyu;
Weng, Jianping;
Paul, Sanjoy K.

Publication type:

Article

Observational Registry of Basal Insulin Treatment ( ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 822, doi. 10.1111/dom.12886

By:

Ji, Linong;
Zhang, Puhong;
Zhu, Dongshan;
Li, Xian;
Ji, Jiachao;
Lu, Juming;
Guo, Xiaohui;
Jia, Weiping;
Weng, Jianping;
Wu, Yangfeng;
Yang, Wenying;
Zou, Dajin;
Zhou, Zhiguang;
Pan, Changyu;
Gao, Yan;
Garg, Satish K.

Publication type:

Article

Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.

Published in:

2019

By:

Kong, Xiaomu;
Xie, Lingding;
Zhu, Haiqing;
Song, Lulu;
Xing, Xiaoyan;
Yang, Wenying;
Chen, Xiaoping

Publication type:

journal article

Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.

Published in:

Advances in Therapy, 2022, v. 39, n. 6, p. 2820, doi. 10.1007/s12325-022-02128-y

By:

Wang, Xin;
Wu, Guangyu;
Shen, Dan;
Zhang, Xia;
Yang, Wenying

Publication type:

Article

Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).

Published in:

Advances in Therapy, 2022, v. 39, n. 1, p. 421, doi. 10.1007/s12325-021-01932-2

By:

Li, Ling;
Yang, Tao;
Xue, Yaoming;
Ruan, Pengfei;
Du, Juan;
Li, Yunguang;
Zhang, Xia;
Cui, Nan;
Yang, Wenying

Publication type:

Article

Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis.

Published in:

Advances in Therapy, 2021, v. 38, n. 3, p. 1470, doi. 10.1007/s12325-021-01637-6

By:

Jiang, Yawen;
Liu, Jia;
Chen, Xin;
Yang, Wenying;
Jia, Weiping;
Wu, Jing

Publication type:

Article

Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.

Published in:

Advances in Therapy, 2020, v. 37, n. 9, p. 3816, doi. 10.1007/s12325-020-01410-1

By:

Ma, Jianhua;
Lei, Minxiang;
Li, Yunguang;
Zhang, Xia;
Cui, Nan;
Yang, Wenying

Publication type:

Article

Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1268, doi. 10.1002/cpt.2877

By:

Wang, Jing;
Liang, Hua;
Wang, You;
Zheng, Xueying;
Chen, Fei;
Shao, Jian;
Geng, Zhaoxu;
Zheng, Li;
Yang, Wenying;
Weng, Jianping;
Xu, Tao;
Zhou, Kaixin

Publication type:

Article

Neutrophil extracellular traps in the cross-talk between periodontitis and chronic kidney disease.

Published in:

BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-05071-2

By:

Hu, Shucheng;
Yang, Ruhan;
Yang, Wenying;
Tang, Jiaqi;
Yu, Weijun;
Zhao, Dan;
Lin, Lu;
Gu, Yuting;
Jin, Min;
Xu, Ziyuan;
Wang, Qin;
Lu, Eryi

Publication type:

Article

Expression patterns of mechanosensitive ion channel PIEZOs in irreversible pulpitis.

Published in:

BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-04209-6

By:

Yang, Wenying;
Lin, Lu;
Hu, Shucheng;
Jiang, Bin;
Yang, Ruhan;
Yu, Weijun;
Tang, Jiaqi;
Zhao, Dan;
Gu, Yuting;
Jin, Min;
Li, Jin;
Lu, Eryi

Publication type:

Article

Phononic Crystal Coupled Mie Structure for Acoustic Amplification.

Published in:

Crystals (2073-4352), 2023, v. 13, n. 8, p. 1196, doi. 10.3390/cryst13081196

By:

Han, Jianning;
Hao, Guodong;
Yang, Wenying;
Zhao, Xinsa

Publication type:

Article

Study on the Effect of Carburizing on the Microstructure and High-Temperature Oxidation Properties of Hot-Dip Aluminum Coating on Titanium Alloy.

Published in:

Coatings (2079-6412), 2023, v. 13, n. 8, p. 1336, doi. 10.3390/coatings13081336

By:

Yang, Wenying;
Li, Faguo

Publication type:

Article

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31328-x

By:

Jiang, Hongwei;
Pang, Shuguang;
Zhang, Yawei;
Yu, Ting;
Liu, Meng;
Deng, Huan;
Li, Li;
Feng, Liqi;
Song, Baili;
Han-Zhang, Han;
Ma, Qingyang;
Qian, Lei;
Yang, Wenying

Publication type:

Article

Maternal and paternal histories differentially influence risks for diabetes, insulin secretion and insulin resistance in a Chinese population.

Published in:

Journal of Diabetes Investigation, 2021, v. 12, n. 3, p. 434, doi. 10.1111/jdi.13360

By:

Kong, Xiaomu;
Yang, Zhaojun;
Zhang, Bo;
Chen, Xiaoping;
Yu, Liping;
Zhu, Haiqing;
Xing, Xiaoyan;
Yang, Wenying

Publication type:

Article

Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial

Published in:

Journal of Diabetes Investigation, 2016, v. 7, n. 1, p. 85, doi. 10.1111/jdi.12364

By:

Yang, Wenying;
Zhu, Lvyun;
Meng, Bangzhu;
Liu, Yu;
Wang, Wenhui;
Ye, Shandong;
Sun, Li;
Miao, Heng;
Guo, Lian;
Wang, Zhanjian;
Lv, Xiaofeng;
Li, Quanmin;
Ji, Qiuhe;
Zhao, Weigang;
Yang, Gangyi

Publication type:

Article

Branched-chain amino acids and the association with type 2 diabetes.

Published in:

2015

By:

Chen, Xiaoping;
Yang, Wenying

Publication type:

Editorial

Epidemic trend of diabetes in China.

Published in:

Journal of Diabetes Investigation, 2014, v. 5, n. 5, p. 478, doi. 10.1111/jdi.12254

By:

Chen, Xiaoping;
Yang, Wenying

Publication type:

Article

Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease.

Published in:

Journal of Diabetes Investigation, 2014, v. 5, n. 4, p. 464, doi. 10.1111/jdi.12172

By:

Chen, Fang;
Yang, Wenying;
Weng, Jianping;
Jia, Weiping;
Ji, Linong;
Xiao, Jianzhong;
Shan, Zhongyan;
Liu, Jie;
Tian, Haoming;
Ji, Qiuhe;
Zhu, Dalong;
Ge, Jiapu;
Lin, Lixiang;
Chen, Li;
Guo, Xiaohui;
Zhao, Zhigang;
Li, Qiang;
Zhou, Zhiguang;
Shan, Guangliang;
Lu, Juming

Publication type:

Article

Association of serine racemase gene variants with type 2 diabetes in the Chinese Han population.

Published in:

Journal of Diabetes Investigation, 2014, v. 5, n. 3, p. 286, doi. 10.1111/jdi.12145

By:

Zhang, Simin;
Xiao, Jianzhong;
Ren, Qian;
Han, Xueyao;
Tang, Yong;
Yang, Wenying;
Zhou, Xianghai;
Ji, Linong

Publication type:

Article

Changing characteristics of the type 2 diabetes epidemic of China and other Asian countries.

Published in:

Journal of Diabetes Investigation, 2013, v. 4, n. 3, p. 223, doi. 10.1111/jdi.12057

By:

Yang, Wenying

Publication type:

Article

Changes in the prevalence of diabetes and control of risk factors for diabetes among Chinese adults from 2007 to 2017: An analysis of repeated national cross‐sectional surveys.

Published in:

Journal of Diabetes, 2024, v. 16, n. 2, p. 1, doi. 10.1111/1753-0407.13492

By:

Jin, Chenye;
Lai, Yaxin;
Li, Yongze;
Teng, Di;
Yang, Wenying;
Teng, Weiping;
Shan, Zhongyan

Publication type:

Article

Cardiovascular disease risk in early‐onset vs late‐onset type 2 diabetes in China: A population‐based cross‐sectional study.

Published in:

Journal of Diabetes, 2024, v. 16, n. 2, p. 1, doi. 10.1111/1753-0407.13493

By:

Chen, Fei;
Yu, Liping;
Xie, Shuo;
Li, Zhaoqing;
Deng, Ruifen;
Jin, Xian;
He, Yifan;
Yang, Zhaojun;
Wang, Yao;
Yang, Wenying;
Zhang, Bo

Publication type:

Article

Yogliptin monotherapy in type 2 diabetes: A 12‐week randomized, double‐blind, placebo‐controlled phase II study.

Published in:

Journal of Diabetes, 2022, v. 14, n. 12, p. 822, doi. 10.1111/1753-0407.13337

By:

Wang, Xin;
Wang, Ying;
Yong, Xiaolan;
Wu, Bojun;
Sun, Zilin;
Lou, Ning;
Wen, Qing;
Zhang, Yufang;
Li, Shiyun;
Li, Jiarui;
He, Yan;
Cheng, Jinluo;
Zhong, Xiangdong;
Shen, Jing;
Yang, Wenying

Publication type:

Article

Patient characteristics and 6‐month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).

Published in:

Journal of Diabetes, 2020, v. 12, n. 9, p. 668, doi. 10.1111/1753-0407.13046

By:

Gao, Leili;
Zhang, Puhong;
Weng, Jianping;
Lu, Juming;
Guo, Xiaohui;
Jia, Weiping;
Yang, Wenying;
Zou, Dajin;
Zhou, Zhiguang;
Pan, Changyu;
Gao, Yan;
Li, Xian;
Zhu, Dongshan;
Wu, Yangfeng;
Garg, Satish K.;
Ji, Linong

Publication type:

Article

Dapagliflozin as add‐on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial.

Published in:

Journal of Diabetes, 2018, v. 10, n. 7, p. 589, doi. 10.1111/1753-0407.12634

By:

Yang, Wenying;
Ma, Jianhua;
Li, Yiming;
Li, Yanbing;
Zhou, Zhiguang;
Kim, Jae Hyeon;
Zhao, June;
Ptaszynska, Agata

Publication type:

Article

Efficacy and safety of dapagliflozin in Asian patients: A pooled analysis.

Published in:

Journal of Diabetes, 2017, v. 9, n. 8, p. 787, doi. 10.1111/1753-0407.12484

By:

Yang, Wenying;
Ji, Linong;
Zhou, Zhiguang;
Cain, Valerie A.;
Johnsson, Kristina M.;
Sjöström, C. David

Publication type:

Article

Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study.

Published in:

2016

By:

Qiuhong Gong;
Ping Zhang;
Jinping Wang;
Yali An;
Gregg, Edward W.;
Hui Li;
Bo Zhang;
Ying Shuai;
Wenying Yang;
Yanyan Chen;
Shuqian Liu;
Engelgau, Michael M.;
Yinghua Hu;
Bennett, Peter H.;
Guangwei Li;
Gong, Qiuhong;
Zhang, Ping;
Wang, Jinping;
An, Yali;
Li, Hui

Publication type:

journal article

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study.

Published in:

Diabetes Care, 2015, v. 38, n. 7, p. 1365, doi. 10.2337/dc14-2498

By:

Yali An;
Ping Zhang;
Jinping Wang;
Qiuhong Gong;
Gregg, Edward W.;
Wenying Yang;
Hui Li;
Bo Zhang;
Ying Shuai;
Yanyan Chen;
Engelgau, Michael M.;
Yiling Cheng;
Yinghua Hu;
Bennett, Peter H.;
Guangwei Li

Publication type:

Article

Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A<sub>1</sub>chieve® observational study.

Published in:

Health & Quality of Life Outcomes, 2014, v. 12, n. 1, p. 137, doi. 10.1186/s12955-014-0137-9

By:

Wenying Yang;
Xiaoming Zhuang;
Yukun Li;
Qing Wang;
Rongwen Bian;
Jianguo Shen;
Hammerby, Eva;
Li Yang

Publication type:

Article

Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study.

Published in:

2014

By:

Yang, Wenying;
Zhuang, Xiaoming;
Li, Yukun;
Wang, Qing;
Bian, Rongwen;
Shen, Jianguo;
Hammerby, Eva;
Yang, Li

Publication type:

journal article

A novel methodology for the optimization of design parameters of electromagnetic relays.

Published in:

Nonlinear Dynamics, 2024, v. 112, n. 4, p. 2909, doi. 10.1007/s11071-023-09189-w

By:

Liu, Lanxiang;
Chen, Zhen;
Yang, Wenying;
Zhai, Guofu;
Zio, Enrico;
Kang, Rui

Publication type:

Article

Attitudes Toward the Mentally Ill in a Sample of Professionals Working in a Psychiatric Hospital in Beijing (China).

Published in:

International Journal of Social Psychiatry, 1999, v. 45, n. 1, p. 41

By:

Sevigny, Robert;
Wenying, Yang;
Peiyan, Zhang;
Marleau, Jacques D.;
Yang Zhouyun;
Su Lin;
Li Guowang;
Xu Dong;
Wang Yanling;
Wang Haijun

Publication type:

Article

Family History of Diabetes and the Effectiveness of Lifestyle Intervention on Insulin Secretion and Insulin Resistance in Chinese Individuals with Metabolic Syndrome.

Published in:

Journal of Diabetes Research, 2021, p. 1, doi. 10.1155/2021/8822702

By:

Zhu, Haiqing;
Chen, Xiaoping;
Zhang, Bo;
Yang, Wenying;
Xing, Xiaoyan

Publication type:

Article